Alaunos Therapeutics Settles Outstanding Invoices with MD Anderson for $285,055
I'm PortAI, I can summarize articles.
Alaunos Therapeutics Inc. has settled disputes with The University of Texas M.D. Anderson Cancer Center over unpaid invoices from a 2019 agreement. The settlement involves Alaunos paying $285,055 in installments from December 2025 to May 2026, with mutual releases of claims. This information was published by Alaunos via the SEC's EDGAR system.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments